Within a little more than a decade, the transplant of human organs for end-stage organ disease became a reality. The early barriers to successful long-term graft and patient survival were related to the inability to effectively control the immune system such that it would not attack the donor tissue but would still recognize and destroy invading organisms and cells. As immunosuppressive therapy has been refined and proper matching of donors and recipients has been improved, hyperacute rejection has become a rare occurrence and acute rejection has been markedly controlled. However, antibody-mediated rejection remains an important impediment to increased survival of transplanted organs. This article provides readers with a broad overview of the immune system, discusses mechanisms of transplant rejection, and details prevention, detection, and treatment of antibody-mediated rejection in solid organ transplant.
Symposium New Interventions in Transplant Michael Petty| July 01 2016
Antibody-Mediated Rejection in Solid Organ Transplant
Michael Petty, RN, PhD, APRN-CNS, CCNS
AACN Adv Crit Care (2016) 27 (3): 316–323.
- Views Icon Views
- Share Icon Share
Michael Petty; Antibody-Mediated Rejection in Solid Organ Transplant. AACN Adv Crit Care 1 July 2016; 27 (3): 316–323. doi: https://doi.org/10.4037/aacnacc2016366
Download citation file: